|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 701 Pennsylvania Ave., NW Suite 720 |
Address2 | |
| City | WASHINGTON |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 5632-12
|
||||||||
|
6. House ID# 312570000
|
||||||||
| TYPE OF REPORT | 8. Year | 2010 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Ronald F. Docksai, Ph.D. Vice President Federal Government Relations |
Date | 07/20/2010 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
HR 1549/S 619 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medially important antibiotics used in the treatment of human and animal diseases; (title II. General provisions in the bill.)
HR 2749 Food Safety Enhancement Act of 2009 to amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food in the global market, and for other purposes; (Title 1 Food Safety. Monitoring food safety provisions.)
HR 2400 Strategies to Address Antimicrobial Resistance; (Section 3(c) relating to authorities over antimicrobial drug data collection.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donna |
Stephens |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ANI
16. Specific lobbying issues
HR 3519/S 1709 Veterinary Services Investment Act; (Support legislation.)
HR 2999 Veterinary Public Health Workforce and Education; (In supoprt for legislation.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donna |
Stephens |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
FY 2011 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act; (General provisions of the bill related to animal drugs and biologics.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donna |
Stephens |
Ms. |
|
|
Jean D. |
Reimers |
Ms. |
|
|
Jennifer |
Spurgat |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CAW
16. Specific lobbying issues
S 787 A bill to amend the Federal Water Pollution Control Act to clarify the jurisdiction of the United States over waters of the United States; (Provisions related to agriculture activities and the section changing the definition of U.S. Waters.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jean D. |
Reimers |
Ms. |
|
|
Jennifer |
Spurgat |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CHM
16. Specific lobbying issues
HR 2868/S 2996 To amend the Homeland Security Act of 2002 to extend, modify, and recodify the authority of the Secretary of Homeland Security to enhance security and protect against acts of terrorism against chemical facilities, and for other purposes; (Provisions related to issues that could affect farmers and those relating to exteneding CFATS regulations, IST provisions and citizen enforcement provisions.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jean D. |
Reimers |
Ms. |
|
|
Jennifer |
Spurgat |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
S 515 A bill to amend title 35 US Code to provide for patent reform: (Sections on damage awards and infringement; Provisions related to apportionment of damages.)
S 1631 Customs Facilitation and Trade Enforcement Reauthorization Act of 2009; (Title II: Subtitle A, B (Sec. 211& 215, Chaps 2 & 3)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ronald F. |
Docksai |
Dr. |
|
|
Karen |
Niedermeyer |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
HR 2999 Veterinary Public Health Workfoce and Education Act; (In support for legislation.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donna |
Stephens |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENV
16. Specific lobbying issues
HR 5210 A bill to amend the Safe Drinking Water Act regarding an endocrine disruptor screening program; (All provisions related to pesticides.)
HR 2454 The American Clean Energy and Security Act of 2009: A bill to create clean energy jobs, achieve energy independence, reduce global warming pollution and transition to a clean energy economy; (All provisions pertaining to the advancement of a
"Cap and Trade" greenhouse gas reduction system and energy efficiency measures.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jean D. |
Reimers |
Ms. |
|
|
Juliane H. |
Van Egmond |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
HR 6228/S 593 The Ban Poisonous Additives Act of 2009: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.)
S 753 The Children's Safe Chemical Act: a ban on food contact materials for children and infants (3 years and under); (All provisions and amendments pertaining to the ban and the testing are relevant.)
HR 4341 Bisphenol-A Consumer Information Act 2009: A bill to amend the Food, Drug and Cosmetic Act to require a warning on the label of any food container that is composed, in whole or in part, of Bisphenol-A or could release Bisphenol-A into the food; (All provisions relating to the science, restricitons on use and applications of Bisphenol-A in food applications.)
HR 2749 Food Safety Enhancement Act of 2009, a reform of the law on food safety protection; (All provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.)
S 510 Food Safety Modernization Act: A bill to modernize the Food and Drug Administration's regulation of food safety; (All provisions related to adding an amendment on Bisphenol-A.)
HR 1332 Safe FEAST Act of 2009: A bill to empower the Food and Drug Administration to more thoroughly protect the food supply.)
S 510 Food Safety and Modernization Act; (All sections.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
Ms. |
|
|
Ronald F. |
Docksai |
Dr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENG
16. Specific lobbying issues
S 1462 American Clean Energy Leadership Act of 2009: A bill to promote clean energy technology development; (All provisions related to enhanced energy efficiency and clean energy development.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HR 1549/S 619 To amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II General provisions in the bill.)
HR 2749 Food Safety Enhancement Act of 2009 to amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food in the global market, and for other purposes; (Title 1 Food Safety. Monitoring food safety provisions.)
HR 2400 Strategies to Address Antimicrobial Resistance; (Section 3(c) relating to authorities over Antimicrobial drug data collection.)
HR 3519/S 1709 Veterinary Services Investment Act; (Support legislation.)
HR 6228/S 593 The Ban Poisonous Additives Act of 2009: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.)
S 753 The Children's Safe Chemical Act: A ban on food contact materials for children and infants (3 years and under); (All provisions and amendments pertaining to the ban and the testing are relevant.)
HR 4341 Bisphenol-A Consumer Information Act 2009: A bill to amend the Food Drug and Cosmetic Act to require a warning on the label of any food container that is composed, in whole or in part of Bisphenol-A or could release Bisphenol-a into the food; (All provisions relating to the science, restrictions on use and applications of Bisphenol-A in food applications.)
HR 2749 Food Safety Enhancement Act of 2009, a reform of the law on food safety protection; (All provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.)
HR 3962 Affordable Health Care for America Act; (Provisions related to subtitle, A,B,C, and D.)
HR 4213 "American Jobs and Closing Tax Loopholes Act of 2010" (Sections pertaining to AMP, and allocation systems; all provisions related to pharmaceuticals and medical devices)
S.Amdt 4369 to HR 4213 In the Nature of a substitute; (Sections pertaining to AMP, and allocation systems.)
HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; (All relating to follow on biologics.)
S 1142 the "Informed Health Care Decisions Making Act of 2009; (sections pertaining to comparative effectiveness.)
HR 1321 Healthy Americans Act; (Relating to Medicare)
HR 3590 Patient Protection and Affordable Care Act; (Sections relating to health insurance and drugs; All provisions relating to healthcare.)
HR 3962 Affordable Health Care for America Act; (Sections relating to health insurance and drugs; All provisions related to pharmaceuticals and medical devices.)
HR 4899 Making Emergency Supplemental Appropriations for Fiscal Year 2010; (All provisions related to pharmaceuticals and medical devices.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donna |
Stephens |
Ms. |
|
|
Juliane H. |
Van Egmond |
Ms. |
|
|
Thomas B. |
Lilburn |
Mr. |
|
|
Julie |
Corcoran |
Ms. |
|
|
Robert D. |
Thomas |
Mr. |
|
|
Ronald F. |
Docksai |
Dr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HOM
16. Specific lobbying issues
HR 2868 Chemical Facility Anti-terrorism Act of 2009: a bill to amend the Homeland Security Act of 2009; (All provisions related to the enhancement and protection of chemical facilities against acts of terrorism.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
Ms. |
|
|
Jean D |
Reimers |
Ms |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
HR 4213 American Jobs and Closing Tax Loopholes Act of 2010; (Sections pertaining to AMP, and allocation systems.)
S.AMDT 4369 to HR 4213 In the nature of a sbustitute; (Sections pertaining to AMP, and allocation systems.)
HR 3590 Patient Protection and Affordable Care Act; (Sections relating to health insurance and drugs.)
HR 3962 Affordable Health Care for America Act; (Sections relating to health insurance and drugs.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Thomas B. |
Lilburn |
Mr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
HR 4213 American Jobs and Closing Tax Loophoses Act of 2010; (Sections pertaining to AMP and allocation systems.)
S.AMDT 4369 to HR 4213 In the nature of a substitute; (Sections pertaining to AMP, and allocation systems.)
HR 1321 Healthy Americans Act; (Relating to Medicare.)
HR 3590 Patient Protection and Affordable Care Act; (Sections relating to health insurance and drugs.)
HR 3962 Affordable Health Care for America Act; (Sections relating to heath insurance and drugs.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Thoms B. |
Lilburn |
Mr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; (All relating to follow-on biologics.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Thomas B. |
Lilburn |
Mr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code RRR
16. Specific lobbying issues
HR 233 The Railroad Antitrust Enforcement Act of 2009: A bill to amend Federal anti-trust laws to provide expanded coverage and to eliminate exceptions from such laws that are contrary to the public interest with respect to railroads. (All provisions pertaining to the "common carrier" provisions of the Staggers Act and injunctive relief for exemptions contrary to the public interest.)
S 146 Railroad Anti-Trust Enforcement Act: A bill to amend the Federal anti-trust laws to provide expanded coverage
and to eliminate exceptions from such laws that are contrary to the public interest with respect to railroads; (All provisions pertaining to the "common carrier" provisions of the Staggers Act and injunctive relief for exemptions contrary to the public interest.)
S 2889 Surface Transportation Reauthorization Act 2009: A bill to reauthorize the Surface Transportation Act and for other purposes; (All provisions related to bottleneck provisions, common carrier, injunctive relief, rate quotation, competition, and service necessary to business and public interest.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAR
16. Specific lobbying issues
HR 4380 Miscellaneous Tariff Bill: to amend the harmonized Tariff schedule and temporarily suspend or modify current rates of tariff; (All provisions related to the tariff bills introduced below:
A bill to extend the temporary suspension of duty on o-Acetylsalicylic acid (Aspirin)
S 2712 A bill to extend the temporary suspension of duty on D-Mannose
S 2168 A bill to extend the suspension of duty on Mixtures of Methyl o-toluenesulonate and methyl p-toluenesulfonate (TSME).
S 2169 A bill to extend the suspension of duty on Trimethylopropane tris(3-aziridinylpropanoate) (Xama 2)
S 2166 A bill to extend the suspension of duty on Polyfunctional aziridine (Xama 7).
S 2187 A bill to extend the suspension of duty on 1,3-Diisocyanatomethylbenzene, polymer with 1,6-diisocyanatohexane (Desmondur VP HL).
S 2189 A bill to extend the suspension of duty on A linear aromatic polyurethane prepolymer based on toluene diisocyanate. (Desmondur E 14)
S 2188 A bill to extend the suspension of duty on Poly(toluene diisocyanate) (Desmondur IL BA).
S 2190 A bill to extend the suspension of duty on Polyisocyanate cross linking agent products containing triphenylmethane triisocyanate in solvents, (Desmondur R-E).
S 2185 A bill to extend suspension of duty on Mixtures of tris(4-isocyanatophenyl)thiophosphate) in solvents, (Desmondur RF-E).
S 2167 A bill to extend the suspension of duty on hexane 1,6, diisocynato-, homopolymer, 3,5, dimethyl-1H-pyrazole-blocked solvents.( Desmodur VP LS 2253)
S 2186 A bill to extend the suspension of duty on Copolymer of methyl ethyl ketoximine and toluene diisocyanate (Desmondur BL XP).
S 2165 A bill to extend the suspension of duty on 2-Oxepanone polymer with 1,4-butanediol and 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane, 2-ethyl-1-hexanol-blocked (Crelan).
A bill to suspend temporarily the duty on Propoxur (Sedran Technical).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
Ms. |
|
|
Karen |
Niedermeyer |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAR
16. Specific lobbying issues
HR4380 A bill to amend the Harmonized Tariff Schedule of the United States to modify temporarily certain rates of duty, and for other purposes. (All provisions related to chemicals listed below)
A bill to suspend temporarily the duty on Olympus WG70
A bill to reduce temporarily the duty on Spirotetramat
A bill to suspend temporarily the duty on Flubendiamide
A bill to reduce temporarily the duty on AE 0172747 Ether
A bill to suspend temporarily the duty on 1,3-Cyclohexanedione.
A bill to extend the temporary suspension of duty on Trichloroacetaldehyde (Chloral)
A bill to extend the temporary suspension of duty on p-chlorobenzaldehyde
A bill to suspend temporarily the duty on mixtures containing 5-Cyclospropyl-4-2(2-Methylsulfonyl-4-Trifluoromethylbenoxyl)Isoxazole (BALANCE PRO)
A bill to suspend temporarily the duty on Isoxaflutole
A bill to extend the reduction of duty on product mixtures containing Iprodione: 3-(3-5,dicholorophenyl)-N-(1-methylethyl)-2,4-dioxo-1-imidazolidinecarboxamide and application adjuvants (ROVRAL)
A bill to extend the temporary suspension of duty on 2-Acetylbutyrolactone
A bill to extend the temporary reduction in duty on Beta-cyfluthrin
A bill to extend the temporary suspension of duty on Cyfluthrin
A bill to temporary suspend the general rate of duty on Clothianidin
A bill to extend the temporary suspension of duty on Ethoprop
A bill to extend the temporary suspension of duty on product mixtures containing Foramsulfuron and Iodosulfuronmethyl-sodium (Equip)
A bill to extend the temporary suspension of duty on Isoxadifen-Ethyl
A bill to extend the temporary reduction of duty on Trifloxystrobin
A bill to extend the temporary suspension of duty on Spiromesifen
A bill to suspend temporarily the duty on Thiencarbazone-methyl
A bill to extend the temporary suspension of duty on FOE Hydroxy
A bill to reduce temporarily the duty on product mixtures containing Tembotrione and application adjuvants ( LAUDIS)
A bill to suspend temporarily the duty on products containing (E)-N-[(2-Chloro-1,3-thiazol-5-yl) methyl]-N-methyl[oxido(oxo)hydrazono] methanediamine or N-[(2-Chloro-1,3-thiazol-5-yl)methyl]-N-{(E)-(methylamino) [oxido(oxo)hydrazono] methyl}amine and application adjucants (PONCHO)
A bill to suspend temporarily the duty on 2(Methylthio)-4-(trifluoromethyl) benzoic acid CAS [142994-05-6]
A bill to suspend temporarily the duty on 2-Chloro-6-(methylthio)toluene (CAS [82961-52-2])
A bill to suspend temporarily the duty on products containing 3-Mesityl-2-oxo-1-oxaspiro[4.4]non-3-en-4-yl 3,3-dimethylbutyrate and application adjuvants (OBERON & FORBID)
A bill to suspend temporarily the duty on mixtures containing Pyrasulfotole: 5-Hydroxy-1,3-dimethylpyrazol-4-yl 2-mesyl-4-(trifluoromethyl)phenyl ketone; and Bromoxynil Octanoate: 2,4-Dibromo-6-cyanophenyl octanoate; and Bromoxynil Heptanoate: 2,4-Dibromo-6-cyanophenyl heptanoate (HUSKIE)
A bill to suspend temporarily the duty on 1,3-Dimethyl-1H-pyrazol-5-ol and 1,3-Dimethylpyrazol-5-one (CAS [5203-77-0], [2749-59-9])
A bill to reduce temporarily the duty on product mixtures containing Thiencarbazone-methyl: Methyl 4-({[(3-methoxy-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)carbonyl]amino}sulfonyl)-5-methylthiophene-3-carboxylate and Isoxadifen-ethyl: ethyl 4,5-dihydro-5,5-diphenyl-1,2-oxazole-3-carboxylate and Tembotrione: 2-{2-Chloro-4-mesyl-3-[(trifluoroethoxy)methyl]benzoyl}cyclohexane-1,3-dione and application adjuvants (HTSUS 3808.93.15; CAS: 317815-83-1, 163520-33-0, 335104-84-2) (CAPRENO)
A bill to suspend temporarily the duty on Cyprosulfamide: N-({4-[(Cyclopropylamino) carbonyl]phenyl}sulfonyl)-2-methoxybenzamide (CAS No. Cyprosulfamide: 221667-31-8)
A bill to extend the temporary reduction of duty on ACM
A bill to reduce temporarily the duty on Oxadiazon
A bill to extend the temporary suspension of duty on mixtures of methyl 4-iodo-2-[3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)ureidosulfonyl] benzoate, sodium salt (Iodosulfuron methyl, sodium salt) and application adjuvants (AUTUMN)
A bill to extend the temporary suspension of duty on Mesosulfuronmethyl
(OSPREY & SILVERADO)
A bill to suspend temporarily the duty on mixtures containing Ethyl(R)-2-[4-(6-chloro-1,3-benzoxazol-2-yloxy)phenoxy]propionate (Fenoxaprop Ethyl), (CAS No. 71283-80-2), 5-hydroxy-1,3-dimethylpyrazol-4-yl 2-mesyl-4-(trifluoromethyl)phenyl ketone (Pyrafulfotole) (CAS No. 365400-11-9), 2,6-dibromo-4-cyanophenyl octanoate (Bromoxynil octanoate) (CAS No. 1689-99-2), and 2,6-dibromo-4-cyanophenyl heptanoate (Bromoxynil heptanoate) (CAS No. 56634-95-8) (WOLVERINE)
A bill to suspend temporarily the duty on 1,2,4 Triazole
A bill to suspend temporarily the duty on Fluopicolide
A bill to suspend temporarily the duty on Fenhexamid
A bill to suspend temporarily the duty on BELT & SYNAPSE
A bill to extend the temporary suspension of duty on Phenmedipham
A bill to extend the temporary suspension of duty on Propiconazole
A bill to extend the temporary suspension of duty on PREVICUR
A bill to extend the temporary suspension of duty on 2,4-dichloroaniline
A bill to extend the temporary reduction in duty of Aluminum tris (O-ethylphosphonate) whether or not mixed with application adjuvants (FOSETYL-AL)
A bill to suspend temporarily the duty on 2,2-Dimethylbutanoic acid 3-(2,4-dichlorophenyl)-2-oxo-1-oxaspiro(4.5)dec-3-en-4-yl ester (Spirodiclofen)
A bill to extend the temporary suspension of duty on Fenamidone
A bill to temporarily suspend the duty on cyclopropane-1,1-dicarboxylic acid, dimethyl ester
A bill to suspend temporarily the duty on Pyrasulfotole
A bill to extend the temporary suspension of duty on Pyrimethanil
A bill to reduce temporarily the duty on CORVUS herbicide
A bill to reduce temporarily the duty on EVERGOL
A bill to reduce temporarily the duty on Imidacloprid Pesticides
A bill to suspend temporarily the duty on LIBERTY, RELY and IGNITE herbicides
A bill to reduce the temporarily the duty on Imidacloprid Technical
A bill to extend the temporary suspension of duty on OPTION & REVOLVER Herbicides
A bill to extend the temporary suspension of duty on 2,6-dibromo-4-cyanophenyl octanoate/heptanoate (Bromoxynil Octanoate / Heptanoate)
A bill to suspend temporarily the product mixtures containing Methyl 2-[({[(4,6-dimethoxy-2-pyrimidinyl)amino]carbonyl}amino)sulfonyl]-4- [(mesylamino)methyl]benzoate (Mesosulfuron-methyl) and Methyl 4-iodo-2-[3-(4-methoxy -6-methyl-1,3,5-triazin-2-yl)ureidosulfonyl]benzoate, sodium salt (Iodosulfuron-methyl-sodium), whether or not mixed with application adjuvants (HTSUS 3808.93.15; CAS 208465-21-8 144550-36-7)
(ATLANTIS)
A bill to suspend temporarily the duty on certain mixtures containing [3-[(6-chloro-3-pridinyl)methyl]-2-thiazolidinylidene]cyanamide (CALYPSO)
A bill to extend the temporary suspension of duty on Permethrin
A bill to extend the temporary suspension of duty on 2-Chlorobenzyl chloride (O-Chlorobenzylchloride)
A bill to suspend temporarily the duty on product mixtures containing Imidacloprid: 1-(6-Chloro-3-pyridinyl)methyl-N-nitroimidazolidin-2-ylidene amine Z9: (9Z)-9-Tricosene (MAXFORCE WG10 & GR0.5)
A bill to extend the temporary suspension of duty on Resmethrin
A bill to extend the temporary suspension of duty on N-3[3-(1-methylethoxy)phenyl]-2-(trifluoromethyl)benzamide (Flutolanil)
A bill to extend the temporary suspension of duty on product mixtures containing 2-(4,5-dihydro-4-methyl-5-oxo-3-propoxy-1H-1,2,4-triazol-1-yl)carboxamidosulfonylbenzoate; sodium (4,5-dihydro-4-methyl-5-oxo-3-propoxy-1H-1,2,4-triazol-1-ylcarbonyl)(2-methoxycarbonylphenylsulfonyl)azanide & methyl 2-[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-a-(methanesulfonamido)-p-toluate (HTSUS 3808.93.15 AND 9902.24.42; CAS 181274-15-7, 208465-21-8) (RIMFIRE & OLYMPUS FLEX)
To suspend temporarily the duty on Tembotrione
A bill to extend the temporary suspension of duty on Deltamethrin
A bill to suspend temporarily the duty on Hydrazine Hydrate Solution
A bill to extend the temporary reduction of duty on Triadimefon (Bayleton
Technical)
A bill to extend the temporary reduction of duty on Ethofumesate in bulk or mixtures.
A bill to reduce temporarily the duty on product mixtures containing Imidacloprid: 1-[(6-chloro-3-pyridinyl)methyl]-N-nitro-2-imidazolidinimine and Cyfluthrin:
Cyano(4-fluoro-3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclo-propanecarboxylate and application adjuvants (HTSUS 3808.91.25; CAS 138261-41-3, 68359-37-5) (LEVERAGE )
A bill to reduce temporarily the duty on product mixtures containing Imidacloprid: 1-[(6-chloro-3-pyridinyl)methyl]-N-nitro-2-imidazolidinimine and Beta-Cyfluthrin:
(RS)-a-cyano-4-fluro-3-phenoxybenzyl(1RS,3RS;1RS,3SR)-2-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate and application adjuvants (HTSUS 3808.91.25; CAS 138261-41-3, 68359-37-5) (LEVERAGE 360)
A bill to reduce temporarily the duty on Benzamide, N-[2-[3-chloro-5 (trifluoromethyl) 2-pyridinyl]ethyl]-2-(trifluoromethyl) (FLUOPYRAM) whether or not mixed with application adjuvants (FLUOPYRAM)
A bill to suspend temporarily the duty on 1,3,5-Triazine-2,4-diamine, N-[(1R,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1-yl]-6-(1-fluoroethyl) (INDAZIFLAM) whether or not mixed with application adjuvants (HTSUS 2933.69.60; CAS 950782-86-2) ) (INDAZIFLAM)
A bill to extend the temporary suspension of duty on Phosphorus Thiochloride (PSCL3)
A bill to extend the temporary suspension of duty on Desmedipham in bulk or mixtures
A bill to extend the temporary suspension of duty on Phenmedipham
Miscellaneous Tarrif Bill: To seek introduction and passage of a bill in the Senate (similar to HR 4380) that would encompass the following bills already introduced in the Senate into a larger package.
S.2691 A bill to reduce temporarily the duty on AE 0172747 Ether.
S.1972 A bill to extend the temporary suspension of duty on mixtures of methyl 4-iodo-2-[3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)ureidosulfonyl] benzoate, sodium salt (Iodosulfuron methyl, sodium salt) and application adjuvants.
S.2689 A bill to reduce the temporary suspension of duty on B-Cyfluthrin.
S.1903 A bill to suspend temporarily the duty on 1,3-Dimethyl-1H-pyrazol-5-ol and 1,3-Dimethylpyrazol-5-one.
S.2489 A bill to suspend temporarily the duty on 2-Chloro-6-(methylthio)toluene.
S.2252 A bill to extend the temporary suspension of duty on Clothianidin.
S.1902 A bill to reduce temporarily the duty on Corvus herbicide.
S.2686 A bill to extend and modify the temporary reduction of duty on cyclopropane-1,1-dicarboxylic acid, dimethyl ester.
S.2257 A bill to extend the temporary suspension of duty on Deltamethrin.
S.1901 A bill to reduce temporarily the duty on Evergol.
S.2684 A bill to extend the temporary suspension of duty on Fenamidone.
S.2069 A bill to extend the temporary suspension of duty on flutolanil.
S.2687 A bill to extend and modify the temporary suspension of duty on Aluminum tris (O-ethylphosphonate).
S.1900 A bill to reduce temporarily the duty on Liberty, Rely, and Ignite herbicides.
S.1971 A bill to extend the suspension of duty on Mesosulfuronmethyl.
S.2253 A bill to extend the temporary suspension of duty on Permethrin.
S.2683 A bill to suspend temporarily the duty on Pyrasulfotole.
S.2262 A bill to extend the temporary suspension of duty on Resmethrin.
S.2690 A bill to reduce and modify the temporary suspension of duty on Iprodione.
S.2688 A bill to extend the temporary suspension of duty on Triadimefon.
S.1970 A bill to suspend temporarily the duty on mixtures containing ethyl (R)-2-[4-(6-chloro-1,3-benzoxazol-2-yloxy)phenoxy]propionate (Fenoxaprop-p-ethyl) (CAS No. 71283-80-2), 5-hydroxy-1,3-dimethylpyrazol-4-yl 2-mesyl-4-(trifluoromethyl)phenyl ketone (Pyrasulfotole) (CAS No. 365400-11-9), 2,6-dibromo-4-cyanophenyl octanoate (Bromoxynil octanoate) (CAS No. 1689-99-2_, and 2,6-dibromo-4-cyanophenyl heptanoate (Bromoxynil heptanoate) (CAS No. 56634-95-8) (provided for in subheading 3808.93.15).
S.2109 A bill to reduce temporarily the duty on mixtures of imidacloprid ((1-[(6-Chloro-3-pyridinyl)methly]-N-nitro-2-imidazolidinimine) with cyfluthrin ((R)-cyano-(4-fluoro-3-phenoxyl)phenyl)methyl (1R,3R)-3-(2.,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate) or its beta-cyfluthrin isomer.
S.2110 A bill to reduce temporarily the duty on Fluopyram.
S.2111 A bill to suspend temporarily the duty on Indaziflam.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jean D. |
Reimers |
Ms. |
|
|
Jennifer |
Spurgat |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAR
16. Specific lobbying issues
Miscellaneous Tariff Bill Bayer CropScience had previously requested several chemicals to be included in the Miscellaneous Tariff Bill that are no longer part of the company's request. Bayer Crop Science has asked that the following bills or chemicals not be included in the Miscellaneous Tariff Bill on the company's behalf.
A bill to suspend temporarily the duty on Thionyl chloride
A bill to suspend the temporary duty suspension on Sodium Methylate Solution
A bill to suspend temporarily the duty on Spiroxamine
A bill to extend the temporary duty suspension on NORTRON SC
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jean D. |
Reimers |
Ms. |
|
|
Jennifer |
Spurgat |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
HR 598 American Recovery and Reinvestment Act of 2009: A bill to expand the research and development tax credit for energy research expenses related to fuel cells, battery technology, renewable energy and carbon capture and sequestration; (All provisions related to research and development.)
HR 2438 To amend the Internal Revenue Code of 1986 to provide temporary bonus research credit for energy for related
research; (All provisions pertaining to the enhanced credit for energy research.)
Protocol Number HP-1350 US France protocol to Income Tax Treaty: (Provisions relating to entire bill.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
Ms. |
|
|
Ronald F. |
Docksai |
Dr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
S 1631 Customs Facilitation and Trade Enforcement Reauthorization Act of 2009; (Provisions relating to Title I: Subtitles A, B, & C, Title II: Subtitle A, B(Sec. 211 & 215, Chaps 2 &3), Title III: Sec. 301-304, 306-307, 311)
HR 4678 Foreign Manufacturers Legal Accountability Act of 2010; (Provisions relating to entire bill.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Karen |
Niedermeyer |
Ms. |
|
|
Ronald F. |
Docksai |
Dr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
HR 2868/S 2996 To amend the Homeland Security Act of 2002 to extend, modify, and recodify the authority of the Secretary of Homeland Security to enhance security and protect against acts of terrorism against chemical facilities, and for other purposes; (Provisions related to issues that could affect farmers and those relating to extending CFATS regulations, IST provisions and citizen enforcement provisions.)
S 787 A bill to amend the Federal Water Pollution Control Act to clarify the jurisdiction of the United States over waters of the United States; (Provisions related to agriculture activities and the section changing the definition of U.S. Waters.)
HR 2454 To create clean energy jobs, achieve energy independence, reduce global warming pollution and transition to a clean energy economy; (All provisions related to agriculture activities, allowances/offsets and credits and the "cap and trade" system for agriculture.)
S 1733 A bill to create clean energy jobs, promote energy independence, reduce global warming pollution, and transition to a clean energy economy; (All provisions related to agriculture, allowances and offsets.)
HR 4159 A bill to amend the Federal Insecticide, Fungicide, and Rodenticide Act to require local educational agencies and schools to implement integrated pest management programs to minimize the use of pesticides in schools and to provide parents, guardians, and employees with notice of the use of pesticides in schools, and for other purposes; (Provisions relating to pesticides.)
S 3535 A bill to enhance the energy security of the United States; (All provisions related to agriculture.)
S 3464 A bill to establish an energy and climate framework; (All provisions related to agriculture.)
Appropriations: Seeking funding for the FY 2011 appropriations; (All provisions related to agriculture, EPA and pesticide fees.)
NPDES permitting issues; (Permitting issues concerning agriculture applications.)
PRIA: pesticide fees; (Reauthorization.)
Regulatory Biotech Issues; (Provisions in proposed regulations regarding the approval of biotech traits and all other issues related to biotech regulations, including APHIS part 340 regs.)
ESA Issues: NMFS Biological opinions; (Discussions on National Marine Fisheries Biological Opinions that we recently released and their potential affects on agriculture.)
ESA Spray Drift: Guidance on spray drift; (Provisions in the guidance related to "may cause harm" and changes to FIFRA.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jean D. |
Reimers |
Ms. |
|
|
Jennifer |
Spurgat |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Appropriations: Seeking funding for the FY 2011 appropriations; (All provisions related to agriculture, EPA and pesticide fees.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jean D. |
Reimers |
Ms. |
|
|
Jennifer |
Spurgat |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address | |
||||||
| City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
| City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |